Gaurav Shah

CEO

Gaurav Shah (CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Rocket Pharmaceuticals, Inc. (RCKT). The largest single filing was $172K of RCKT (55,684 sh × $3.09, as filed), executed May 21.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$172K

shares × price, as filed

Last traded

May 21

Filed May 26

Median ADV $8.0M across their filed names

Open performance→

Volume by month

Buys $102K Sells $489K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names

RCKT

Rocket Pharmaceuticals, Inc. RCKT · 1 buy · 3 sells 4 filings

Recent filings

RCKTSALE Rocket Pharmaceuticals, Inc. View filing → $172K
55,684 sh × $3.09
Exec May 21
Filed May 26 · 5:30 PM ET RCKTPURCHASE Rocket Pharmaceuticals, Inc. View filing → $102K
20,000 sh × $5.08
Exec Apr 10 2025
Filed Apr 14 2025 · 5:30 PM ET RCKTSALE Rocket Pharmaceuticals, Inc. View filing → $172K
16,303 sh × $10.58
Exec Feb 21 2025
Filed Feb 25 2025 · 5:30 PM ET RCKTSALE Rocket Pharmaceuticals, Inc. View filing → $145K
11,091 sh × $13.05
Exec Nov 21 2024
Filed Nov 25 2024 · 5:30 PM ET